Raltitrexed (Tomudex™) plus doxorubicin (DOX) in patients with advanced gastric cancer:: Interim results of a phase I dose escalation study

被引：0
|
作者：
Bjarnason, G [1 ]
Charpentier, D [1 ]
Winquist, E [1 ]
Wong, R [1 ]
Matthews, S [1 ]
Seymour, L [1 ]
机构：
[1] NCI, Canada Clin Trials Grp, Kingston, ON, Canada
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
459
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [41] Phase II study of raltitrexed (Tomudex) as second-line treatment in advanced colorectal cancer (ACC)
    Santoro, M
    Santoro, A
    Maiorino, L
    Forestieri, V
    Forestieri, P
    ANNALS OF ONCOLOGY, 1998, 9 : 45 - 45
  • [42] The combination of raltitrexed (Tomudex) and mitomycin-C in the treatment of advanced colorectal cancer - A phase II study
    Michels, J.
    Geldart, T.
    Darby, A.
    Craddock, L.
    Iveson, A.
    Richardson, L.
    Iveson, T.
    CLINICAL ONCOLOGY, 2006, 18 (06) : 431 - 435
  • [43] Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma -: Results of a phase I-II trial
    Scheithauer, W
    Kornek, GV
    Ulrich-Pur, H
    Penz, M
    Raderer, M
    Salek, T
    Haider, K
    Kwasny, W
    Depisch, D
    CANCER, 2001, 91 (07) : 1264 - 1271
  • [44] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [45] Phase I dose escalation study of abexinostat and doxorubicin in patients with metastatic sarcomas.
    Choy, Edwin
    Balasubramanian, Sriram
    Butrynski, James
    Morgan, Jeffrey
    Sirisawad, Mint
    Mani, Chitra
    George, Suzanne
    Wagner, Andrew
    Harmon, David
    Rubinstein, Yael
    Duan, Zhenfeng
    Hornicek, Francis
    Demetri, George
    CANCER RESEARCH, 2013, 73 (08)
  • [46] Phase I trial of radiation dose escalation in patients with locally advanced hepatocellular carcinoma: An interim report
    Zhao, J.
    Ren, Z.
    Jiang, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S15 - S15
  • [47] Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
    S Danson
    D Ferry
    V Alakhov
    J Margison
    D Kerr
    D Jowle
    M Brampton
    G Halbert
    M Ranson
    British Journal of Cancer, 2004, 90 : 2085 - 2091
  • [48] Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer
    Kim, Yeul Hong
    Seo, Hee Yeon
    Jeen, Yoon Tae
    Kim, Hoon-Kyo
    Shim, Byoung Yong
    Yang, Jinmo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 253 - 260
  • [49] Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer
    Yeul Hong Kim
    Hee Yeon Seo
    Yoon Tae Jeen
    Hoon-Kyo Kim
    Byoung Yong Shim
    Jinmo Yang
    Cancer Chemotherapy and Pharmacology, 2009, 63
  • [50] Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer
    Danson, S
    Ferry, D
    Alakhov, V
    Margison, J
    Kerr, D
    Jowle, D
    Brampton, M
    Halbert, G
    Ranson, M
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2085 - 2091
12345